Both of these studies attribute the sex bias in cancer to AR-mediated regulation of Tcf7/TCF1 in CD8+ T cells and the subsequent differentiation to dysfunctional T cells; however, the former ascribed a positive regulatory role while the latter a negative regulatory role. The gene discussed is CD8A; the disease is cancer.